View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

CVS Health Corporation: Update to credit analysis following outlook re...

Our credit view of this issuer reflects its solid prescription drug fundamentals, offset by its execution risk related to expansion into primary care.

Moody's Ratings affirms CVS's Baa2/P-2 ratings; revises outlook to neg...

Moody's Ratings (Moody's) affirmed the ratings of CVS Health Corporation ("CVS") including the Baa2 senior unsecured notes, (P)Baa2 senior unsecured shelf and Prime-2 senior unsecured commercial paper rating. At the same time, we revised CVS's outlook to negative from stable. The affirmation of th...

 PRESS RELEASE

EQS-News: Alles auf Rot - Aus „antwerpes“ wird 'DocCheck Agency“

EQS-News: DocCheck AG / Schlagwort(e): Sonstiges Alles auf Rot - Aus „antwerpes“ wird 'DocCheck Agency“ 17.07.2024 / 10:38 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Die DocCheck AG plant die Umbenennung der antwerpes Agenturgruppe. Sie soll zum 4. Quartal 2024 erfolgen. „Wir werden im Healthcare-Markt künftig nur noch mit einer Marke auftreten. Und die ist rot.“ so Dr. Frank Antwerpes, CEO der DocCheck AG.  Die Agenturgruppe bleibt unter der neuen Firmierung als eigenständige Einheit bestehen. Parallel zur Umbenennung wird die k...

Moody's Ratings assigns Baa2 rating to CVS's sr. unsecured notes; outl...

Moody's Ratings (Moody's) assigned a Baa2 rating to the new senior unsecured notes issuance of CVS Health Corporation ("CVS"). There are no changes to CVS's existing ratings including the Baa2 senior unsecured long-term rating or the Prime-2 commercial paper rating. The outlook remains unchanged at ...

CVS Health Corp: 2 directors

Two Directors at CVS Health Corp bought 10,181 shares at between 53.879USD and 54.492USD. The significance rating of the trade was 98/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over th...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: May 2, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

EQS-News: Vorläufige Zahlen zum ersten Quartal 2024

EQS-News: DocCheck AG / Schlagwort(e): Quartalsergebnis Vorläufige Zahlen zum ersten Quartal 2024 02.05.2024 / 18:29 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Die DocCheck Gruppe (ISIN DE000A1A6WE6) gibt heute vorläufige Zahlen für das erste Quartal 2024 bekannt. Die Umsatzerlöse der ersten drei Monate 2024 betragen 12,1 Millionen Euro (Vorjahr: 13,7 Millionen Euro). Der daraus erzielte EBIT liegt bei 1,0 bis 1,1 Millionen Euro (Vorjahr: 1,2 Millionen Euro). Die rückläufige Umsatz- und Ergebnisentwicklung resultiert aus einem s...

Moody's: CVS's challenges in Medicare Advantage will persist

Moody's Ratings ("Moody's") commented on CVS Health Corporation's (Baa2 stable) continuing pressure in its Medicare Advantage business, which prompted a significant downward revision in 2024 earnings guidance. These events are credit negative because of the impact on CVS's financial leverage, with g...

CVS Health Corporation: Challenges in Medicare Advantage will persist

Profit pressures will cause higher leverage, but financial levers and earnings growth in 2025 will benefit credit ratios.

CVS Health Corporation: Key facts and statistics - 2023

A summary company profile, detailing CVS Health Corporation’s business operations and financial highlights.

CVS Health Corporation: Update to credit analysis following ratings af...

Our credit view of this issuer reflects its large scale and breadth and solid prescription drug trends, tempered by execution risk related to expansion into primary care.

CVS Health Corporation: Update to credit analysis following ratings af...

Our credit view of this issuer reflects its large scale and breadth and solid prescription drug trends, tempered by execution risk related to expansion into primary care.

Moody's affirms CVS Health's Baa2 ratings; stable outlook

Moody's Investors Service ("Moody's") affirmed the ratings of CVS Health Corporation ("CVS") including the Baa2 senior unsecured notes ratings, the Prime-2 senior unsecured commercial paper rating and the (P)Baa2 senior unsecured shelf rating. The outlook is maintained stable. The affirmation foll...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: November 11, 2023

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

BAC BANK OF AMERICA CORP
ZBRA ZEBRA TECHNOLOGIES CORPORATION CLASS A
UAL UNITED AIRLINES HOLDINGS INC.
SEIC SEI INVESTMENTS COMPANY
SBCF SEACOAST BANKING CORPORATION OF FLORIDA
MKL MARKEL CORPORATION
MAA MID-AMERICA APARTMENT COMMUNITIES INC.
HUN HUNTSMAN CORPORATION
EL ESTEE LAUDER COMPANIES INC. CLASS A
DIN DINE BRANDS GLOBAL INC.
CVS CVS HEALTH CORPORATION
CNP CENTERPOINT ENERGY INC.
B BARNES GROUP INC.
APH AMPHENOL CORPORATION CLASS A
ALGN ALIGN TECHNOLOGY INC.
ALB ALBEMARLE CORPORATION
OSTK OVERSTOCK.COM INC.
AROW ARROW FINANCIAL CORP.
TEX TEREX CORPORATION
CYH COMMUNITY HEALTH SYSTEMS INC.
PETS PETMED EXPRESS INC.
UEIC UNIVERSAL ELECTRONICS INC.
FCPT FOUR CORNERS PROPERTY TRUST INC.
EPD ENTERPRISE PRODUCTS PARTNERS L.P.
BSM BLACK STONE MINERALS LP
NQP NUVEEN PENNSYLVANIA INVESTMENT QUALITY MUNICIPAL FUND INC.
MSBI MIDLAND STATES BANCORP
XOM EXXON MOBIL CORPORATION
NXJ NUVEEN NEW JERSEY DIVIDEND ADVANTAGE MUNICIPAL FUND
AES THE AES CORPORATION
CXH MFS INVESTMENT GRADE MUNICIPAL TRUST
BY BYLINE BANCORP
XPO XPO LOGISTICS EUROPE SA
MPB MID PENN BANCORP INC.
NWPP NEW PEOPLES BANKSHARES INC.
RBB RBB BANCORP
INTZ INTRUSION
EML THE EASTERN COMPANY
NVST ENVISTA HOLDINGS
GCI GANNETT CO. INC.
AMPY AMPLIFY ENERGY
ENX EATON VANCE NEW YORK MUNICIPAL BOND FUND
KYMR KYMERA THERAPEUTICS
WSC WILLSCOT MOBILE MINI HOLDINGS CORP
BALY BALLYS CORPORATION
DLHC DALEIGH HOLDINGS CORP
RPTX REPARE THERAPEUTICS
PACK RANPAK HOLDINGS (A)
LUMN LUMEN TECHNOLOGIES INC.
COFS CHOICEONE FINANCIAL SERVICES
LFMD LIFEMD
SOFI INC.
SRPT SOFI TECHNOLOGIES INC
KBR SAREPTA THERAPEUTICS
INC.
KBR
INC.
Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch